1. Home
  2. FCEL vs CRVS Comparison

FCEL vs CRVS Comparison

Compare FCEL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

HOLD

Current Price

$15.85

Market Cap

1.2B

Sector

Energy

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$12.96

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCEL
CRVS
Founded
1969
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
FCEL
CRVS
Price
$15.85
$12.96
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$8.31
$30.17
AVG Volume (30 Days)
8.2M
661.6K
Earning Date
06-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
5.24
48.04
EPS
N/A
N/A
Revenue
$89,437,000.00
N/A
Revenue This Year
$4.77
N/A
Revenue Next Year
$42.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.71
$5.64
52 Week High
$37.88
$26.95

Technical Indicators

Market Signals
Indicator
FCEL
CRVS
Relative Strength Index (RSI) 41.28 36.72
Support Level $6.93 $12.76
Resistance Level $25.06 $14.00
Average True Range (ATR) 1.39 0.56
MACD -0.17 -0.16
Stochastic Oscillator 28.86 10.78

Price Performance

Historical Comparison
FCEL
CRVS

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: